Bhidayasiri Roongroj, Truong Daniel D
Chulalongkorn Comprehensive Movement Disorders Center, Division of Neurology, Chulalongkorn University Hospital, Bangkok 10330, Thailand.
J Neurol Sci. 2008 Mar 15;266(1-2):204-15. doi: 10.1016/j.jns.2007.08.028. Epub 2007 Sep 27.
Long-term dopaminomimetic therapy, not limited to levodopa, is complicated by the emergence of variations of motor response in a majority of Parkinson disease (PD) patients. These variations can occur in different forms, as early wearing off during the initial stage of motor complications, dyskinesias in the intermediate stage, and complex fluctuations in the advanced stage. Considered to be a major source of disability in advanced PD patients, recognition of these complications is critical in order to develop different strategies designed not only to treat these problems when they develop, but also to prevent troublesome complications associated with potential risk factors. In this article, authors classify a wide clinical spectrum of motor complications into different stages as the disease progresses through the treatment. A number of strategies are proposed in order to manage these complications as well as to avoid them. Better understanding of these potential complications will result in better management of these problems and lessen the disability associated with advanced PD.
长期多巴胺能模拟疗法(不限于左旋多巴)会使大多数帕金森病(PD)患者出现运动反应变化,从而变得复杂。这些变化可以有不同形式,如运动并发症初期的早期疗效减退、中期的异动症以及晚期的复杂波动。这些并发症被认为是晚期PD患者致残的主要原因,认识到这些并发症对于制定不同策略至关重要,这些策略不仅要在并发症出现时进行治疗,还要预防与潜在风险因素相关的麻烦并发症。在本文中,作者根据疾病在治疗过程中的进展,将广泛的运动并发症临床谱分为不同阶段。为了管理和避免这些并发症,提出了一些策略。更好地理解这些潜在并发症将有助于更好地管理这些问题,并减轻与晚期PD相关的残疾。